117 related articles for article (PubMed ID: 11078333)
1. 'Irreversible' endothelin-1 binding does not prohibit ABT-627 from reversing endothelin-1-induced effects.
Chiou WJ; Wessale JL; von Geldern T; Opgenorth TJ; Wu-Wong JR
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S48-52. PubMed ID: 11078333
[TBL] [Abstract][Full Text] [Related]
2. Evidence for vasoconstriction mediated by the endothelin-B receptor in domestic swine.
Burke SE; Nelson RA; Lubbers NL; Ford TT; Fu KI; Padley RJ; Wegner CD; Cox BF
J Cardiovasc Pharmacol; 2000 Jun; 35(6):838-44. PubMed ID: 10836715
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of A-216546: a highly selective antagonist for endothelin ET(A) receptor.
Wu-Wong JR; Dixon DB; Chiou WJ; Dayton BD; Novosad EI; Adler AL; Wessale JL; Calzadilla SV; Hernandez L; Marsh KC; Liu G; Szczepankiewicz B; von Geldern TW; Opgenorth TJ
Eur J Pharmacol; 1999 Feb; 366(2-3):189-201. PubMed ID: 10082200
[TBL] [Abstract][Full Text] [Related]
4. ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain.
Jarvis MF; Wessale JL; Zhu CZ; Lynch JJ; Dayton BD; Calzadilla SV; Padley RJ; Opgenorth TJ; Kowaluk EA
Eur J Pharmacol; 2000 Jan; 388(1):29-35. PubMed ID: 10657544
[TBL] [Abstract][Full Text] [Related]
5. Selective ET(A) receptor antagonism with ABT-627 attenuates all renal effects of endothelin in humans.
Honing MLH; Hijmering ML; Ballard DE; Yang YP; Padley RJ; Morrison PJ; Rabelink TJ
J Am Soc Nephrol; 2000 Aug; 11(8):1498-1504. PubMed ID: 10906163
[TBL] [Abstract][Full Text] [Related]
6. Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure.
Francis B; Winaver J; Karram T; Hoffman A; Abassi Z
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S54-8. PubMed ID: 15838359
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: ex vivo and in vivo studies.
Wessale JL; Adler AL; Novosad EI; Calzadilla SV; Dayton BD; Marsh KC; Winn M; Jae HS; von Geldern TW; Opgenorth TJ; Wu-Wong JR
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():112S-117S. PubMed ID: 12193067
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamic effects of ABT-627, an oral ETA selective endothelin antagonist, in humans.
Verhaar MC; Grahn AY; Van Weerdt AW; Honing ML; Morrison PJ; Yang YP; Padley RJ; Rabelink TJ
Br J Clin Pharmacol; 2000 Jun; 49(6):562-73. PubMed ID: 10848720
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of peripheral and spinal endothelin receptors in the micturition reflex in rats.
Ogawa T; Kamo I; Pflug BR; Nelson JB; Seki S; Igawa Y; Nishizawa O; de Groat WC; Chancellor MB; Yoshimura N
J Urol; 2004 Oct; 172(4 Pt 1):1533-7. PubMed ID: 15371886
[TBL] [Abstract][Full Text] [Related]
10. Effects of selective and non-selective endothelin receptor blockade on ET-1-induced pressor response in the hamster.
Honoré JC; Fecteau MH; Wessale JL; D'Orléans-Juste P
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S68-71. PubMed ID: 15838362
[TBL] [Abstract][Full Text] [Related]
11. Effects of endothelin receptor antagonists on the plasma immunoreactive endothelin-1 level.
Opgenorth TJ; Wessale JL; Dixon DB; Adler AL; Calzadilla SV; Padley RJ; Wu-Wong JR
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S292-6. PubMed ID: 11078402
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: in vitro studies.
Wu-Wong JR; Dixon DB; Chiou WJ; Sorensen BK; Liu G; Jae HS; Tasker A; von Geldern TW; Winn M; Opgenorth TJ
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():107S-111S. PubMed ID: 12193066
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist.
Nishikibe M; Ohta H; Okada M; Ishikawa K; Hayama T; Fukuroda T; Noguchi K; Saito M; Kanoh T; Ozaki S; Kamei T; Hara K; William D; Kivlighn S; Krause S; Gabel R; Zingaro G; Nolan N; O'Brien J; Clayton F; Lynch J; Pettibone D; Siegl P
J Pharmacol Exp Ther; 1999 Jun; 289(3):1262-70. PubMed ID: 10336515
[TBL] [Abstract][Full Text] [Related]
14. Type A, but not type B, endothelin receptor antagonists significantly decrease portal pressure in portal hypertensive rats.
De Gottardi A; Shaw S; Sägesser H; Reichen J
J Hepatol; 2000 Nov; 33(5):733-7. PubMed ID: 11097480
[TBL] [Abstract][Full Text] [Related]
15. The effects of diminishing albumin binding to some Endothelin receptor antagonists.
Szczepankiewicz BG; Bal RB; von Geldern TW; Wu-Wong JR; Chiou WJ; Dixon DB; Opgenorth TJ; Hoffman DJ; Borre AJ; Marsh KC; Nguyen BN
Life Sci; 1998; 63(21):1905-12. PubMed ID: 9825768
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension.
Bianciotti LG; de Bold AJ
Cardiovasc Res; 2001 Mar; 49(4):808-16. PubMed ID: 11230980
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat.
Saleh MA; Boesen EI; Pollock JS; Savin VJ; Pollock DM
Hypertension; 2010 Nov; 56(5):942-9. PubMed ID: 20823379
[TBL] [Abstract][Full Text] [Related]
18. Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonist.
Yuyama H; Noguchi Y; Fujimori A; Ukai M; Fujiyasu N; Ohtake A; Sato S; Sudoh K; Sasamata M; Miyata K
Eur J Pharmacol; 2004 Sep; 498(1-3):171-7. PubMed ID: 15363992
[TBL] [Abstract][Full Text] [Related]
19. Dipeptide sulfonamides as endothelin ETA/ETB receptor antagonists.
Ksander GM; Shetty SS; DelGrande D; Balwierczak JL; Bruseo CW; Savage P; deJesus R; Yuan A; Webb RL; Jeng AY
Can J Physiol Pharmacol; 2002 May; 80(5):464-9. PubMed ID: 12056554
[TBL] [Abstract][Full Text] [Related]
20. Pyrrolidine-3-carboxylic acids as endothelin antagonists. 5. Highly selective, potent, and orally active ET(A) antagonists.
Jae HS; Winn M; von Geldern TW; Sorensen BK; Chiou WJ; Nguyen B; Marsh KC; Opgenorth TJ
J Med Chem; 2001 Nov; 44(23):3978-84. PubMed ID: 11689084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
